The c-Myc target gene network

Dang, Chi V., O’Donnell, Kathryn A., Zeller, Karen I., Nguyen, Tam, Osthus, Rebecca C., Li, Feng·2006·Seminars in Cancer Biology

Cited by (1,000)

Items 301–400 of 1,000

  1. Burkitt’s lymphoma-associated c-Myc mutations converge on a dramatically altered target gene response and implicate Nol5a/Nop56 in oncogenesis
    Victoria H. Cowling, Scott A. Turner, Michael D. Cole · 2013 · Oncogene
  2. Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populations
    Colleen Jayne Saunders, Lize van der Merwe, Michael Posthumus, Jill L. Cook, Christopher J. Handley, Malcolm Collins, Alison Victoria September · 2012 · Journal of Orthopaedic Research®
  3. Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic Targets
    Bora Gürel, Tsuyoshi Iwata, Cheryl M. Koh, Srinivasan Yegnasubramanian, William G. Nelson, Angelo Michael De Marzo · 2008 · Advances in Anatomic Pathology
  4. Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes
    Yangying Zhou, Zhijie Xu, Wei Lin, Yumei Duan, Can Lu, Wei Liu, Weiping Su, Yuanliang Yan, Huan Liu, Li Liu et al. · 2019 · Frontiers in Oncology
  5. MYC and the Art of MicroRNA Maintenance
    James N. Psathas, Andrei Thomas‐Tikhonenko · 2014 · Cold Spring Harbor Perspectives in Medicine
  6. RETRACTED: Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
    Wenlong Feng, Dylan C. Dean, Francis John Hornicek, Dimitrios Spentzos, Robert M. Hoffman, Huirong Shi, Zhenfeng Duan · 2020 · Therapeutic Advances in Medical Oncology · Retracted
  7. MYC TRANSCRIPTION FACTORS: KEY REGULATORS BEHIND ESTABLISHMENT AND MAINTENANCE OF PLURIPOTENCY
    Keriayn N. Smith, S. Dalton · 2010 · Regenerative medicine
  8. Carbon Nanotube as a Tool for Fighting Cancer
    Edson José Comparetti, Valber A. Pedrosa, Ramon Kaneno · 2017 · Bioconjugate Chemistry
  9. c-mycand N-mycpromote active stem cell metabolism and cycling as architects of the developing brain
    Alice Wey, Paul S. Knoepfler · 2010 · Oncotarget
  10. Differential Effects on ARF Stability by Normal versus Oncogenic Levels of c-Myc Expression
    Delin Chen, Ning Kon, Jiayun Zhong, Pingzhao Zhang, Long Yu, Wei Jun Gu · 2013 · Molecular Cell
  11. Ursolic Acid from Oldenlandia diffusa Induces Apoptosis via Activation of Caspases and Phosphorylation of Glycogen Synthase Kinase 3 Beta in SK-OV-3 Ovarian Cancer Cells
    Young-Hoon Song, Soo‐Jin Jeong, Hee Young Kwon, Bonglee Kim, Sung‐Hoon Kim, Dong-Youl Yoo · 2012 · Biological and Pharmaceutical Bulletin
  12. Inhibition of 5-Lipoxygenase Selectively Triggers Disruption of c-Myc Signaling in Prostate Cancer Cells
    Sivalokanathan Sarveswaran, Debrup Chakraborty, Dhananjay Arun Chitale, Rosalie C. Sears, Jagadananda Ghosh · 2014 · Journal of Biological Chemistry
  13. Mycotherapy of Cancer: An Update on Cytotoxic and Antitumor Activities of Mushrooms, Bioactive Principles and Molecular Mechanisms of their Action
    Višnja B. Popović, Jelena Živković, Slobodan Davidović, Milena J. Stevanović, Dejan S. Stojković · 2013 · Current Topics in Medicinal Chemistry
  14. Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer
    Liqun Yang, Qian Lei, Lin Li, Jie Yang, Zhen Dong, Hongjuan Cui · 2019 · Clinical Epigenetics
  15. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells
    Chi Zhang, Wen Yuan, Ying Wu, Xu Wan, Yanling Gong · 2020 · Life Sciences
  16. Fimepinostat (CUDC‐907) in patients with relapsed/refractory diffuse large B cell and high‐grade B‐cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses
    Daniel Jeffrey Landsburg, Stefan Klaus Barta, Radhakrishnan Ramchandren, Connie Lee Batlevi, Swaminathan P. Iyer, Kevin R. Kelly, Ivana N. Micallef, Sonali M. Smith, Don Ambrose Stevens, Mariano J. Alvarez et al. · 2021 · British Journal of Haematology
  17. Tumor-associated macrophages (TAMs) depend on MMP1 for their cancer-promoting role
    Junhui Yu, Zhengshui Xu, Jing Guo, Kui Yang, Jianbao Zheng, Xuejun Sun · 2021 · Cell Death Discovery
  18. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity
    Yuqin Di, Xiaoqian Jing, Kunhua Hu, Xiangqiong Wen, Lvlan Ye, Xiang Zhang, Jiale Qin, Jinning Ye, Run Lin, Ziyang Wang et al. · 2022 · Drug Resistance Updates
  19. MALAT1-KTN1-EGFR regulatory axis promotes the development of cutaneous squamous cell carcinoma
    Ying Zhang, Lin Gao, Shudong Ma, Ji Ma, Yinghui Wang, Shanshan Li, Xia Hu, Shuo Han, Meijuan Zhou, Liang Zhou et al. · 2019 · Cell Death and Differentiation
  20. SENEBLOC, a long non-coding RNA suppresses senescence via p53-dependent and independent mechanisms
    Cheng Xu, Ben Sang, Guangzhi Liu, Jinming Li, Xu Dong Zhang, Lian Xin Liu, Rick Francis Thorne, Mian Wu · 2020 · Nucleic Acids Research
  21. C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle
    Aaron K Olson, Dolena R. Ledee, Kate Iwamoto, Masaki Kajimoto, Colleen M. O′Kelly Priddy, Nancy Isern, Michael A. Portman · 2012 · Journal of Molecular and Cellular Cardiology
  22. The tumor suppressor role of CTCF
    Francesco Paolo Fiorentino, Antonio Giordano · 2011 · Journal of Cellular Physiology
  23. Chemoprevention of B-Cell Lymphomas by Inhibition of the Myc Target Spermidine Synthase
    TachaZi Plym Forshell, Sara Rimpi, Jonas A. Nilsson · 2010 · Cancer Prevention Research
  24. The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer
    Kha Wai Hon, Syafiq Asnawi Zainal Abidin, Iekhsan Othman, Rakesh Naidu · 2021 · Frontiers in Pharmacology
  25. Small-Molecule Modulators of c-Myc/Max and Max/Max Interactions
    Thorsten Berg · 2010 · Current topics in microbiology and immunology
  26. c-Myc, RMRP, and miR-34a-5p form a positive-feedback loop to regulate cell proliferation and apoptosis in multiple myeloma
    Xichun Xiao, Yueli Gu, Genjie Wang, Shuxia Chen · 2018 · International Journal of Biological Macromolecules
  27. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells
    Zhaoxia Niu, Huaying Liu, Ming Zhou, Heran Wang, Yukun Liu, Xiayu Li, Wei Xiong, Jian Ma, Xiaoling Li, Guiyuan Li · 2015 · Acta Biochimica et Biophysica Sinica
  28. Immortalization and malignant transformation of Eukaryotic cells
    Aleksei A. Stepanenko, VADIM M. KAVSAN · 2012 · Cytology and Genetics
  29. Highly multiplexed and quantitative cell-surface protein profiling using genetically barcoded antibodies
    Samuel B. Pollock, Amy Hu, Yun Mou, Alexander J. Martinko, Olivier Julien, Michael J. Hornsby, Lynda Ploder, Jarrett Adams, Huimin Geng, Markus Müschen et al. · 2018 · Proceedings of the National Academy of Sciences
  30. Sterically Stabilized siRNA:Gold Nanocomplexes Enhance c-MYC Silencing in a Breast Cancer Cell Model
    Aliscia Nicole Daniels, Moganavelli Singh · 2019 · Nanomedicine
  31. Redundant Role for Early Growth Response Transcriptional Regulators in Thymocyte Differentiation and Survival
    John H. Carter, Juliette M. Lefebvre, David L. Wiest, Warren G. Tourtellotte · 2007 · The Journal of Immunology
  32. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL
    Candace J. Poole, Atul Lodh, Jeong-Hyeon Choi, Jan van Riggelen · 2019 · Epigenetics & Chromatin
  33. Global gene expression and functional network analysis of gastric cancer identify extended pathway maps and GPRC5A as a potential biomarker
    Lei Cheng, Sheng Yang, Yanqing Yang, Wen Zhang, Huasheng Xiao, Hengjun Gao, Xiaxing Deng, Qinghua Zhang · 2012 · Cancer Letters
  34. Interaction between MYC and MCL1 in the Genesis and Outcome of Non–Small-Cell Lung Cancer
    Thaddeus D. Allen, Chang‐Qi Zhu, Kirk D. Jones, Naoki Yanagawa, Ming‐Sound Tsao, J. Michael Bishop · 2011 · Cancer Research
  35. Circadian disruption promotes tumor growth by anabolic host metabolism; experimental evidence in a rat model
    Natalí N. Guerrero‐Vargas, Raful Navarro-Espíndola, Mara A. Guzmán‐Ruiz, María del Carmen Basualdo, Estefania Espítia‐Bautista, Ana López-Bago, Ricardo Lascuraín, Cinthya Córdoba-Manilla, Ruud M. Buijs, Carolina Escobar · 2017 · BMC Cancer
  36. Drosophila Myc: A master regulator of cellular performance
    Daniela Grifoni, Paola Bellosta · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
  37. Cartilage tissue engineering identifies abnormal human induced pluripotent stem cells
    Akihiro Yamashita, Shiying Liu, Knut Woltjen, Bradley Thomas, Guoliang Meng, Akitsu Hotta, Kazutoshi Takahashi, James Ellis, Shinya Yamanaka, Derrick E. Rancourt · 2013 · Scientific Reports
  38. MicroRNA-135a Inhibits Cell Proliferation by Targeting Bmi1 in Pancreatic Ductal Adenocarcinoma
    Zheng Dang, Weihua Xu, Peng Lu, Nan Wu, Jie Liu, Bai Ruan, Liang Zhou, Wenjie Song, Kefeng Dou · 2014 · International Journal of Biological Sciences
  39. Molecular targeted study in tumors: From western medicine to active ingredients of traditional Chinese medicine
    Ruixiao Li, Qi Li, Qing Ji · 2019 · Biomedicine & Pharmacotherapy
  40. Long noncoding RNA CMPK2 promotes colorectal cancer progression by activating the FUBP3–c-Myc axis
    Qingzu Gao, Rui Zhou, Yuan Meng, Rongfei Duan, Ling Wu, Rui Li, Fengliu Deng, Chuang Lin, Liang Zhao · 2020 · Oncogene
  41. Novel insights in cell cycle dysregulation during prostate cancer progression
    Salma Ben‐Salem, Varadha Balaji Venkadakrishnan · 2021 · Endocrine Related Cancer
  42. MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition
    Mark R. Silvis, Dilru Silva, Riley Rohweder, Sophia S. Schuman, Swapna Aravind Gudipaty, Amanda Truong, Jeffrey T. Yap, Kajsa E. Affolter, Martin McMahon, Conan Grant Kinsey · 2022 · The Journal of Experimental Medicine
  43. Acting Locally and Globally: Myc's Ever-Expanding Roles on Chromatin
    Natalia V. Varlakhanova, Paul S. Knoepfler · 2009 · Cancer Research
  44. Reconstructing networks of pathways via significance analysis of their intersections
    Mirko Francesconi, Daniel Remondini, Nicola Neretti, John M. Sedivy, Leon N. Cooper, Ettore Verondini, Luciano Milanesi, Gastone Castellani · 2008 · BMC Bioinformatics
  45. Analysis of epigenetic alterations to chromatin during development
    Meghan E. Minard, Abhinav K. Jain, Michelle Craig Barton · 2009 · genesis
  46. c-Myc induced upregulation of long non-coding RNA SNHG16 enhances progression and carcinogenesis in oral squamous cell carcinoma
    Shangfeng Li, Shengkai Zhang, Jie Chen · 2019 · Cancer Gene Therapy
  47. An extended Myc network contributes to glucose homeostasis in cancer and diabetes
    W. Peterson Christopher · 2011 · Frontiers in bioscience
  48. Molecular Targets and Signaling Pathways of microRNA-122 in Hepatocellular Carcinoma
    Kwang‐Hoon Chun · 2022 · Pharmaceutics
  49. Cancer genome and tumor microenvironment: Reciprocal crosstalk shapes lung cancer plasticity
    Siavash Mansouri, Daniel Heylmann, Thorsten Stiewe, Michael Kracht, Rajkumar Savai · 2022 · eLife
  50. Interference with the β-catenin gene in gastric cancer induces changes to the miRNA expression profile
    Dong Li, Jun Deng, Ze-Min Sun, An-Ping Pan, Xiaojun Xiang, Ling Zhang, Feng Yu, Jun Chen, Zhe Sun, Feng Miao et al. · 2015 · Tumor Biology
  51. Discovery of a Natural Product-Like c-myc G-Quadruplex DNA Groove-Binder by Molecular Docking
    Dik‐Lung Ma, Daniel Shiu‐Hin Chan, Wai Chung Fu, Hong‐Zhang He, Hui Yang, Siu‐Cheong Yan, Chung‐Hang Leung · 2012 · PLoS ONE
  52. The Tumor Suppressor Protein HBP1 Is a Novel c-Myc-binding Protein That Negatively Regulates c-Myc Transcriptional Activity
    Julienne R. Escamilla‐Powers, Colin J. Daniel, Amy Farrell, Karyn L. Taylor, Xiaoli Zhang, Sarah A. Byers, Rosalie C. Sears · 2009 · Journal of Biological Chemistry
  53. Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma
    Harriet E. D. Southgate, Lindi Chen, Nicola J. Curtin, Deborah A. Tweddle · 2020 · Frontiers in Oncology
  54. Noninvasive molecular imaging of c-Myc activation in living mice
    Hua Fan-Minogue, Zhongwei Cao, Ramasamy Paulmurugan, Carmel T. Chan, Tarik F. Massoud, Dean W. Felsher, Sanjiv Sam Gambhir · 2010 · Proceedings of the National Academy of Sciences
  55. High MYC mRNA Expression Is More Clinically Relevant than MYC DNA Amplification in Triple-Negative Breast Cancer
    Eriko Katsuta, Li Yan, Takashi Takeshita, Kerry-Ann McDonald, Subhamoy Dasgupta, Mateusz Opyrchal, Kazuaki Takabe · 2019 · International Journal of Molecular Sciences
  56. Natural products as glycolytic inhibitors for cervical cancer treatment: A comprehensive review
    Qun Liu, Xiuhan Chen, Yurong Tan, Jiao Liu, Mingya Zhu, Delin Li, Yijie Zhou, Tiane Zhang, Qiao zhi Yin · 2024 · Biomedicine & Pharmacotherapy
  57. Wnt/Myc interactions in intestinal cancer: Partners in crime
    Kevin Myant, Owen James Sansom · 2011 · Experimental Cell Research
  58. Viral-Mediated Noisy Gene Expression Reveals Biphasic E2f1 Response to MYC
    Jeffrey V. Wong, Guang Yao, Joseph Roy Nevins, Lingchong You · 2011 · Molecular Cell
  59. Crude alkaloid extract of Rhazya stricta inhibits cell growth and sensitizes human lung cancer cells to cisplatin through induction of apoptosis
    Ayman I. Elkady · 2013 · Genetics and Molecular Biology
  60. TIMELESS contributes to the progression of breast cancer through activation of MYC
    Limin Chi, Yujiao Zou, Ling Qin, Weifeng Ma, Yanyan Hao, Yaoliang Tang, Rongcheng Luo, Ziqing Wu · 2017 · Breast Cancer Research
  61. Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation
    Yiyu Zhang, Aleksandra Dakic, Renxiang Chen, Yuhai Dai, Richard Schlegel, Xuefeng Liu · 2017 · Oncotarget
  62. Keratin 23 Is a Peroxisome Proliferator‐Activated Receptor Alpha–Dependent, MYC‐Amplified Oncogene That Promotes Hepatocyte Proliferation
    Donghwan Kim, Chad N. Brocker, Shogo Takahashi, Tomoki Yagai, Taehyeong Kim, Guomin Xie, Hua Wang, Aijuan Qu, Frank J. Gonzalez · 2019 · Hepatology
  63. Methylselenol, a Selenium Metabolite, Plays Common and Different Roles in Cancerous Colon HCT116 Cell and Noncancerous NCM460 Colon Cell Proliferation
    Huawei Zeng, Mary Briske‐Anderson, Min Wu, Mary Pat Moyer · 2011 · Nutrition and Cancer
  64. c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer
    Caggiano, Cinzia, Pieraccioli, Marco, Panzeri, Valentina, Sette, Claudio, Bielli, Pamela · 2019 · Nucleic Acids Research
  65. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
    Ka Iong Chan, Siyuan Zhang, Guodong Li, Yida Xu, Liao Cui, Yitao Wang, Huanxing Su, Wen Tan, Zhangfeng Zhong · 2024 · Aging and Disease
  66. Methylselenol, a selenium metabolite, modulates p53 pathway and inhibits the growth of colon cancer xenografts in Balb/c mice
    Huawei Zeng, Wen‐Hsing Cheng, LuAnn K. Johnson · 2012 · The Journal of Nutritional Biochemistry
  67. Genome-wide gain-of-function screen identifies novel regulators of pluripotency
    Ramzey Abujarour, Jem A. Efe, Sheng Ding · 2010 · Stem Cells
  68. A Brief History of Apoptosis: From Ancient to Modern Times
    Aristidis Diamantis, Emmanouil Magiorkinis, George H. Sakorafas, George Androutsos · 2008 · Oncology Research and Treatment
  69. c-Myc activates BRCA1 gene expression through distal promoter elements in breast cancer cells
    Ying-Hua Chen, Jinhua Xu, S. Borowicz, C. Collins, D. Huo, O. Olopade · 2011 · BMC Cancer
  70. Truncated Form of TGF-βRII, But Not Its Absence, Induces Memory CD8+ T Cell Expansion and Lymphoproliferative Disorder in Mice
    Harumichi Ishigame, Munir M. Mosaheb, Shomyseh Sanjabi, Richard Anthony Flavell · 2013 · The Journal of Immunology
  71. MiR-494 Inhibits Epithelial Ovarian Cancer Growth by Targeting c-Myc
    Jialing Yuan, Kana Wang, Mingrong Xi · 2016 · Medical Science Monitor
  72. MYC promotes cancer progression by modulating m6A modifications to suppress target gene translation
    Gongwei Wu, Caixia Suo, Ying Yang, Shengqi Shen, Linchong Sun, Shiting Li, Yingli Zhou, Dongdong Yang, Yan Wang, Yongping Cai et al. · 2021 · EMBO Reports
  73. Gene expression regulation and cancer
    M. Dolores Delgado, Javier León · 2006 · Clinical & Translational Oncology
  74. Aspirin and salicylic acid decrease c-Myc expression in cancer cells: a potential role in chemoprevention
    Guoqiang Ai, Rakesh Dachineni, Pratik Muley, Hemachand Tummala, G. Jayarama Bhat · 2015 · Tumor Biology
  75. STK33 promotes hepatocellular carcinoma through binding to c-Myc
    Tian Yang, Bin Song, Jin Zhang, Guang-Shun Yang, Han Zhang, Weifeng Yu, Mengchao Wu, Jun‐Hua Lu, Feng Shen · 2014 · Gut
  76. Exercise tames the wild side of the Myc network: a hypothesis
    Kishorchandra Gohil, George A. Brooks · 2012 · American Journal of Physiology-Endocrinology and Metabolism
  77. Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis
    S Liu, Nicole R. Tackmann, Jing Yang, Yingao Zhang · 2016 · Oncogene
  78. Cardiac-specific ablation of the E3 ubiquitin ligase Mdm2 leads to oxidative stress, broad mitochondrial deficiency and early death
    Ludger Hauck, Shanna Stanley-Hasnain, Amelia Fung, Daniela Grothe, Vivek Rao, Tak W. Mak, Filio Billia · 2017 · PLoS ONE
  79. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia
    Karen A. Urtishak, Li-San Wang, Biljana Čuljković, James W. Davenport, Patrizia Porazzi, Tiffaney L. Vincent, David T. Teachey, Sarah Kathleen Tasian, Jonni S. Moore, Alix Eden Seif et al. · 2018 · Oncogene
  80. Cell surface GRP78 signaling: An emerging role as a transcriptional modulator in cancer
    Udhayakumar Gopal, Salvatore Vincent Pizzo · 2020 · Journal of Cellular Physiology
  81. Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers
    Atharva S. Torne, Erle S. Robertson · 2024 · Cancers
  82. Aberrations of MYC Are a Common Event in B-Cell Prolymphocytic Leukemia
    Ellen M. Flatley, Andy I. Chen, Xiangrong Zhao, Elaine S. Jaffe, Jennifer B. Dunlap, Stefania Pittaluga, Shahed Azzam Ahmed Abdullah, Susan B. Olson, Stephen E. F. Spurgeon, Guang Fan · 2014 · American Journal of Clinical Pathology
  83. Protein-leucine ingestion activates a regenerative inflammo-myogenic transcriptome in skeletal muscle following intense endurance exercise.
    D. Rowlands, André R. Nelson, F. Raymond, S. Métairon, R. Mansourian, Jim Clarke, T. Stellingwerff, Stuart M Phillips · 2016 · Physiological Genomics
  84. KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1
    Mei-Ting Qiu, Qiong Fan, Zhu Zhu, Suet‐Ying Kwan, Limo Chen, Jin-Hong Chen, Zuo-Lin Ying, Ye Zhou, Wei Ting Gu, Li-Hua Wang et al. · 2015 · Oncotarget
  85. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression
    Z-H Liu, J-L Hu, J-Z Liang, A-J Zhou, M-Z Li, S-M Yan, X Zhang, Song Gao, Liang Chen, Qian Zhong et al. · 2015 · Cell Death and Disease
  86. Aspirin regulation of c-myc and cyclinD1 proteins to overcome tamoxifen resistance in estrogen receptor-positive breast cancer cells
    Ran Cheng, Ya-Jing Liu, Junwei Cui, Man Yang, Xiaoling Liu, Peng Li, Zhan Wang, Lizhang Zhu, Siyi Lu, Li Zou et al. · 2017 · Oncotarget
  87. C-Myc regulates PD-L1 expression in esophageal squamous cell carcinoma.
    Mingqiang Liang, Fengqiang Yu, Chun Chen · 2020 · PubMed Central
  88. Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction
    Peter S. Choi, Jan van Riggelen, Andrew J. Gentles, Pavan Bachireddy, Kavya Rakhra, Stacey J. Adam, Sylvia K. Plevritis, Dean W. Felsher · 2011 · Proceedings of the National Academy of Sciences
  89. Tumor-Suppressive Activity of the Cell Death Activator GRIM-19 on a Constitutively Active Signal Transducer and Activator of Transcription 3
    Sudhakar Kalakonda, Shreeram C. Nallar, Daniel J. Lindner, Jiadi Hu, Sekhar P. Reddy, Dhananjaya V. Kalvakolanu · 2007 · Cancer Research
  90. Activated α2-Macroglobulin Regulates Transcriptional Activation of c-MYC Target Genes through Cell Surface GRP78 Protein
    Udhayakumar Gopal, Mario Gonzalez–Gronow, Salvatore Vincent Pizzo · 2016 · Journal of Biological Chemistry
  91. The roles of HLH transcription factors in epithelial mesenchymal transition and multiple molecular mechanisms
    Yue Teng, Li Xu · 2013 · Clinical & Experimental Metastasis
  92. Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer
    Yuqing Lu, Yuewen Yang, Guanghao Zhu, Hairong Zeng, Yi‐Ming Fan, Fujia Guo, Dongshu Xu, Boya Wang, Dapeng Chen, Guang‐Bo Ge · 2023 · International Journal of Biological Sciences
  93. G-quadruplexes in cancer-related gene promoters: from identification to therapeutic targeting
    Francesca Romano, Anna Di Porzio, Nunzia Iaccarino, Gelsomina Riccardi, Ritamaria Di Lorenzo, Sonia Laneri, Bruno Pagano, Jussara Amato, Antonio Randazzo · 2023 · Expert Opinion on Therapeutic Patents
  94. Cancer stem cells: a target for overcoming therapeutic resistance and relapse
    Shuo Zhang, Rui Yang, Yujie Ouyang, Yang Shen, Lanlin Hu, Chuan Shan Xu · 2024 · Cancer Biology and Medicine
  95. Direct and indirect targeting of MYC to treat acute myeloid leukemia
    Sam Brondfield, Sushma Umesh, Alexandra N. Corella, Johannes A. Zuber, Amy Rappaport, Coline M Gaillard, Scott W. Lowe, Andrei Goga, Scott C. Kogan · 2015 · Cancer Chemotherapy and Pharmacology
  96. Direct regulation of HSP60 expression by c‐MYC induces transformation
    Ya‐Ping Tsai, Shu‐Chun Teng, Kou‐Juey Wu · 2008 · FEBS Letters
  97. miR-17-92 cluster components analysis in Burkitt lymphoma: overexpression of miR-17 is associated with poor prognosis
    Marcela Cristina Robaina, Roberta Soares Faccion, Luciano Mazzoccoli, Lídia Maria Magalhães de Rezende, Eduardo Queiroga, Carlos E. Bacchi, Andrei Thomas‐Tikhonenko, Claudete Esteves Klumb · 2016 · Annals of Hematology
  98. Stabilization of c-myc G-Quadruplex DNA, inhibition of telomerase activity, disruption of mitochondrial functions and tumor cell apoptosis by platinum(II) complex with 9-amino-oxoisoaporphine
    Jiao-Lan Qin, Qi‐Pin Qin, Zu‐Zhuang Wei, Yan-Cheng Yu, Ting Meng, Chenxuan Wu, Yuelan Liang, Hong Liang, Zhen‐Feng Chen · 2016 · European Journal of Medicinal Chemistry
  99. c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma
    Kamini Singh, Jianan Lin, Yi Zhong, Antonija Burčul, Prathibha Mohan, Man Jiang, Liping Laura Sun, Vladimir Yong‐Gonzalez, Agnes J. Viale, Justin R. Cross et al. · 2019 · The Journal of Experimental Medicine
  100. hTERT, MYC and TP53 deregulation in gastric preneoplastic lesions
    Tanielly Cristina Raiol Silva, Mariana Ferreira Leal, Danielle Queiroz Calcagno, Carolina Rosal Teixeira de Souza, André Salim Khayat, Ney Pereira Carneiro dos Santos, Raquel Carvalho Montenegro, Sílvia Helena Barem Rabenhorst, Mayara Quaresma Nascimento, Paulo Pimentel de Assumpção et al. · 2012 · BMC Gastroenterology